Literature DB >> 15519760

Immunolocalization of 14-3-3 isoforms in brains with Pick body disease.

Takahiko Umahara1, Toshiki Uchihara, Kuniaki Tsuchiya, Ayako Nakamura, Kenji Ikeda, Toshihiko Iwamoto, Masaru Takasaki.   

Abstract

Immunolocalization of 14-3-3 protein isoforms in relation to Pick bodies in Pick body disease (PBD) brains was investigated. Weakly granular immunoreactivity of 14-3-3 proteins was found in neurons in control subjects and in Pick body disease brains. In addition to this granular immunoreactivity, many Pick bodies were immunopositive for 14-3-3 proteins as confirmed with double-immunofluorescence with an anti-PHF tau (AT8) and anti-14-3-3 that recognizes all its isoforms (common). When probed with isoform-specific antibodies, Pick bodies were positive for beta, gamma, epsilon, eta, tau, and zeta isoform and exhibited immunostaining pattern similar to that observed with the anti-14-3-3 proteins (common). In addition, immunoreactivity of sigma isoform, so far considered to be exclusively extraneuronal, was unexpectedly found in Pick bodies, normal hippocampal neurons and brain homogenate from age-matched controls. Although localization of 14-3-3 proteins in Pick bodies suggests their involvement in Pick body formation, their role may be variable dependent on the isoforms differently expressed in different area in the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519760     DOI: 10.1016/j.neulet.2004.08.079

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Authors:  Yazi D Ke; Gabriella Chan; Kristie Stefanoska; Carol Au; Mian Bi; Julius Müller; Magdalena Przybyla; Astrid Feiten; Emmanuel Prikas; Glenda M Halliday; Olivier Piguet; Matthew C Kiernan; Michael Kassiou; John R Hodges; Clement T Loy; John S Mattick; Arne Ittner; Jillian J Kril; Greg T Sutherland; Lars M Ittner
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

Review 2.  14-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology.

Authors:  Takahiko Umahara; Toshiki Uchihara
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

3.  Arachidonic acid binds 14-3-3zeta, releases 14-3-3zeta from phosphorylated BAD and induces aggregation of 14-3-3zeta.

Authors:  Thomas G Brock
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

Review 4.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

5.  Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death.

Authors:  Hyung-Wook Kim; Yunyoung C Chang; Mei Chen; Stanley I Rapoport; Jagadeesh S Rao
Journal:  BMC Neurosci       Date:  2009-09-28       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.